TMT quantitative proteomics reveals key proteins relevant to microRNA-1-mediated regulation in osteoarthritis

Pinpin Jiang1,2, Dan Liang2,3, Hang Wang4

  • 1Department of Orthopaedic Surgery, the Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.

Proteome Science
|November 23, 2023
PubMed

Insights

MicroRNA-1 (miR-1) treatment reduced MMP-13 expression in rodent osteoarthritis models. Proteomic analysis identified key proteins regulated by miR-1, offering insights into osteoarthritis therapeutic mechanisms.

Area of Science:

  • Molecular Biology
  • Proteomics
  • Osteoarthritis Research

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease with incompletely understood pathogenic mechanisms.
  • MicroRNAs, such as microRNA-1 (miR-1), are implicated in regulating gene expression and cellular processes relevant to OA.
  • Identifying the molecular targets and regulatory networks of miR-1 is crucial for understanding its therapeutic potential in OA.

Purpose of the Study:

  • To investigate the mechanisms of microRNA-1 (miR-1) treatment in rodent models of osteoarthritis (OA).
  • To identify differentially expressed proteins (DEPs) regulated by miR-1 in OA cartilage using a proteomic approach.
  • To elucidate the potential therapeutic mechanisms of miR-1 in OA pathogenesis.

Main Methods:

  • Rodent models of osteoarthritis were established using anterior cruciate ligament transection in rats and destabilization of the medial meniscus (DMM) in mice.
  • Intra-articular administration of miR-1 agomir (rats) or tamoxifen to induce miR-1 expression (mice) was performed.
  • Tandem mass tagging (TMT) quantitative proteomic analysis was used to identify DEPs, followed by RT-qPCR validation of selected targets.

Main Results:

  • Immunohistochemical analysis showed significantly lower MMP-13 expression in miR-1 treated rats.
  • Proteomic analysis in mice identified 345 differentially expressed proteins out of 3526 identified proteins.
  • Key proteins including Fn1, P4ha1, and Acan were identified as potential miR-1 targets, with validated differential expression of their transcripts.

Conclusions:

  • MicroRNA-1 (miR-1) demonstrates therapeutic potential in osteoarthritis by modulating key protein expression networks.
  • Proteomic analysis successfully identified novel miR-1 targets, such as Fn1, P4ha1, and Acan, involved in OA regulation.
  • These findings provide valuable insights into the molecular mechanisms underlying miR-1's therapeutic effects in osteoarthritis.